Pantoea dispersa bacteremia in an immunocompetent patient: a case report and review of the literature.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
13 Feb 2019
Historique:
received: 27 03 2018
accepted: 02 01 2019
entrez: 14 2 2019
pubmed: 14 2 2019
medline: 14 6 2019
Statut: epublish

Résumé

Pantoea is a Gram-negative, non-encapsulated, non-spore-forming, ubiquitous straight rod which can be isolated from geographical and ecological sources such as plant surfaces, buckwheat seeds, human feces, and the environment. The genus Pantoea is a rare pathogen in a clinical setting, and is divided into 20 different species such as Pantoea agglomerans, Pantoea ananatis, Pantoea deleyi, Pantoea dispersa, Pantoea septica, Pantoea stewartii or Pantoea rwandensis. Pantoea dispersa has been reported to cause other infections, including respiratory infections, neonatal sepsis, and bloodstream infections. We report a case of Pantoea dispersa bacteremia caused by acute cholangitis. This is the first case report of Pantoea dispersa bacteremia caused by acute cholangitis as far as we had searched. A 38-year-old Japanese woman suffered from acute cholangitis; a blood culture showed that Gram-negative rod was positive. The treatment was successful with intravenously administered meropenem, and it was switched to orally administered levofloxacin according to microbiological susceptibility. The organism was identified as Pantoea dispersa by both genetic investigation by 16S ribosomal RNA and additional biochemical tests. To the best of our knowledge, this is the first case report of Pantoea dispersa bacteremia caused by acute cholangitis. The epidemiology and clinical features of Pantoea dispersa are still unknown. More cases of infections caused by Pantoea dispersa might be revealed with advancing technical methods, such as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry or 16S ribosomal RNA analysis. Physicians must know that a variety of infections caused by Pantoea dispersa could occur in immunocompromised as well as immunocompetent patients.

Sections du résumé

BACKGROUND BACKGROUND
Pantoea is a Gram-negative, non-encapsulated, non-spore-forming, ubiquitous straight rod which can be isolated from geographical and ecological sources such as plant surfaces, buckwheat seeds, human feces, and the environment. The genus Pantoea is a rare pathogen in a clinical setting, and is divided into 20 different species such as Pantoea agglomerans, Pantoea ananatis, Pantoea deleyi, Pantoea dispersa, Pantoea septica, Pantoea stewartii or Pantoea rwandensis. Pantoea dispersa has been reported to cause other infections, including respiratory infections, neonatal sepsis, and bloodstream infections. We report a case of Pantoea dispersa bacteremia caused by acute cholangitis. This is the first case report of Pantoea dispersa bacteremia caused by acute cholangitis as far as we had searched.
CASE PRESENTATION METHODS
A 38-year-old Japanese woman suffered from acute cholangitis; a blood culture showed that Gram-negative rod was positive. The treatment was successful with intravenously administered meropenem, and it was switched to orally administered levofloxacin according to microbiological susceptibility. The organism was identified as Pantoea dispersa by both genetic investigation by 16S ribosomal RNA and additional biochemical tests. To the best of our knowledge, this is the first case report of Pantoea dispersa bacteremia caused by acute cholangitis.
CONCLUSION CONCLUSIONS
The epidemiology and clinical features of Pantoea dispersa are still unknown. More cases of infections caused by Pantoea dispersa might be revealed with advancing technical methods, such as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry or 16S ribosomal RNA analysis. Physicians must know that a variety of infections caused by Pantoea dispersa could occur in immunocompromised as well as immunocompetent patients.

Identifiants

pubmed: 30755259
doi: 10.1186/s13256-019-1969-z
pii: 10.1186/s13256-019-1969-z
pmc: PMC6373044
doi:

Substances chimiques

Anti-Bacterial Agents 0
Levofloxacin 6GNT3Y5LMF
Meropenem FV9J3JU8B1

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Références

Infection. 2003 Jan;31(1):66-7
pubmed: 12608369
Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1571-8
pubmed: 23818163
Braz J Infect Dis. 2013 Nov-Dec;17(6):726-8
pubmed: 24120830
Braz J Infect Dis. 2014 Nov-Dec;18(6):696-7
pubmed: 25179511
FEMS Microbiol Rev. 2015 Nov;39(6):968-84
pubmed: 26109597

Auteurs

Nobuhiro Asai (N)

Department of Clinical Infectious Diseases, Aichi Medical University Hospital, 〒480-1195 1-1 Yazakokarimata, Nagakute, Aichi, Japan.
Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

Yusuke Koizumi (Y)

Department of Clinical Infectious Diseases, Aichi Medical University Hospital, 〒480-1195 1-1 Yazakokarimata, Nagakute, Aichi, Japan.
Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

Atsuko Yamada (A)

Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

Daisuke Sakanashi (D)

Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

Hiroki Watanabe (H)

Department of Clinical Infectious Diseases, Aichi Medical University Hospital, 〒480-1195 1-1 Yazakokarimata, Nagakute, Aichi, Japan.
Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

Hideo Kato (H)

Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

Arufumi Shiota (A)

Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

Mao Hagihara (M)

Department of Clinical Infectious Diseases, Aichi Medical University Hospital, 〒480-1195 1-1 Yazakokarimata, Nagakute, Aichi, Japan.
Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

Hiroyuki Suematsu (H)

Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

Yuka Yamagishi (Y)

Department of Clinical Infectious Diseases, Aichi Medical University Hospital, 〒480-1195 1-1 Yazakokarimata, Nagakute, Aichi, Japan.
Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

Hiroshige Mikamo (H)

Department of Clinical Infectious Diseases, Aichi Medical University Hospital, 〒480-1195 1-1 Yazakokarimata, Nagakute, Aichi, Japan. mikamo@aichi-med-u.ac.jp.
Department of Infection Control and Prevention, Aichi Medical University Hospital, Nagakute, Aichi, Japan. mikamo@aichi-med-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH